KCM
VXRT

Kathmere Capital Management’s Vaxart VXRT Stock Holding History

Kathmere Capital Management’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,000
Closed -$29K – 405
2020
Q4 		$29K Buy
5,000
+3,000
+150% +$19.1K 0.01% 269
2020
Q3 		$13K Buy
+2,000
New +$17.8K ﹤0.01% 287

Other funds holding VXRT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Kathmere Capital Management's VXRT Position: Q1 2021 in Review

Kathmere Capital Management sold out of Vaxart (VXRT) in Q1 2021, closing a stake of 5,000 shares — an estimated $29K sold.

Kathmere Capital Management first reported a position in VXRT in Q3 2020 and held it in 2 quarters. The position peaked at $29K in Q4 2020. 159 funds tracked by Wall St. Rank hold VXRT as of Q1 2021.

  • Kathmere Capital Management reported no remaining Vaxart position as of Q1 2021 after selling out during the quarter.
  • Kathmere Capital Management sold 5,000 Vaxart shares in Q1 2021, an estimated $29K.
  • Kathmere Capital Management first reported a position in Vaxart in Q3 2020 and held it in 2 quarters.
  • Kathmere Capital Management's Vaxart position peaked at $29K in Q4 2020.
  • 159 funds tracked by Wall St. Rank held Vaxart as of Q1 2021.

Based on Kathmere Capital Management's 13F filing for Q1 2021, filed 7 May 2021.